$1.13
-0.05[-4.24%]
At close: Apr 17
$1.13
0[0.00%]
After Hours: 8:26AM EDT
Akari Therapeutics
(NASDAQ:AKTX)Akari Therapeutics Stock (NASDAQ:AKTX), Quotes and News Summary
Akari Therapeutics Stock (NASDAQ: AKTX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 12.627K |
| Day Range | - - - |
| 52 Wk Range | 1.078 - 5.500 |
| Market Cap | $8.954M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 34 |
| Short Interest | 0.22% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Akari Therapeutics Plc
Sector
Health Care
Industry
Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing th...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akari Therapeutics (AKTX) stock?
You can purchase shares of Akari Therapeutics (NASDAQ: AKTX) through any online brokerage.
Who are Akari Therapeutics's (AKTX) competitors?
Other companies in Akari Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
What is the target price for Akari Therapeutics (AKTX) stock?
The latest price target for Akari Therapeutics (NASDAQ: AKTX) was reported by HC Wainwright & Co. on Monday, December 5, 2022. The analyst firm set a price target for 1.50 expecting AKTX to rise to within 12 months (a possible 27.12% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Akari Therapeutics (AKTX)?
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $1.18 last updated April 22, 2024 at 3:46 PM EDT.
Does Akari Therapeutics (AKTX) pay a dividend?
There are no upcoming dividends for Akari Therapeutics.
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics’s FY earnings are confirmed for Monday, April 1, 2024.
Is Akari Therapeutics (AKTX) going to split?
There is no upcoming split for Akari Therapeutics.
What sector and industry does Akari Therapeutics (AKTX) operate in?
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.